An accomplished Melbourne-based company director and CEO with 18 year’s experience, able to fill the needs of boards seeking to expand capability in healthcare, precision medicine, life-sciences, information technology, M&A, investment, commercialisation, globalization and compliance.

Richard has recently been covered in Forbes magazine regarding his company Applied Precision Medicine, one of a portfolio of 4 companies he has created over a 7 year period. His success in Healthcare, Medical Device, and Digital Health sectors showcases an ability to identify and pursue emerging markets using proven adaptive business models under strong compliance and governance.

At Oracle Corporation, Richard owned several product divisions with responsibility for global strategy in sales, marketing, consulting, product development, education and support. He led technical and commercial due diligence in many Oracle acquisitions. Richard is also media trained and has worked with journalists in the United States and Australia. Richard was an advisory board founder at iSelect Pty Ltd where he returned in 2008 as CIO to deliver significant business restructuring to support new insurance markets building iSelect’s next chapter in digital strategy. iSelect listed on the ASX in June 2013 at a value of AU$300M. 

Matt Kilpatrick


Matt is a highly experienced corporate executive and advisor who has successfully undertaken numerous business development roles, facilitated major projects and provided strategic business consulting.


Matt is known for his effective strategic leadership, efficient project management and “hands on” approach and is a team-orientated and flexible leader, with a proven ability to produce results and strengthen organizations.


Matt is able to work with a wide range of people in situations of both organizational growth and crisis. Matt is a creative and competent problem solver with strong lateral thinking abilities, a key negotiator for licensing and distribution agreements and is able to implement continuous improvement strategies to increase investor attractiveness in projects, while managing Government, investor and technology partners’ involvement and expectations.

Luke Whelan

Co-Developer of Vpatch & CTO

Luke spent his earlier career in the finance industry looking after the capital and asset requirements of his clients. In the 1990’s he became involved in a series of medical innovations by developing a successful R&D investment syndicate which listed on the stock market in 2000, giving Luke a wealth of experience as a senior executive of a public company before he left to pursue other interests.


Luke teamed up with Peter Taylor to establish a medical device company working on a variety of recognition algorithms to partially automate some aspects of critical care medicine. Vpatch was part of the product group and Luke has been instrumental in the evolution and development of the product.

Please reload

© 2020 Vpatch Cardio Pty Ltd - Privacy Policy